Gut Microbiota in Interaction Effects of Periodontitis and Hyperlipidemia

doi:10.13701/j.cnki.kqyxyj.2021.02.001

Abstract

Abstract: Periodontitis and hyperlipidemia are common chronic diseases that seriously affect human health. It is reported that there is a positive relationship between them. However, the exact biological mechanisms are still unclear. Intestinal microecosystem is the largest and most complex ecosystem in human body. Multiple studies have confirmed that the gut microbiota can regulate blood lipids and bone metabolism through its own metabolites, affecting host metabolism and immune response. Both periodontitis and hyperlipidemia can cause changes in the composition of intestinal microbiota. This review aims to deliver an overview of the interaction effects of periodontitis and hyperlipidemia via gut microbiota and provide some new ideas and theoretical bases to improve the recognition of relationship between two diseases.

Key words: periodontitis, hyperlipidemia, gut microbiota

YAN Fuhua, HUANG Yuezhen. Gut Microbiota in Interaction Effects of Periodontitis and Hyperlipidemia[J]. Journal of Oral Science Research, 2021, 37(2): 95-100.

References

[1] 闫福华.牙周炎对全身疾病和健康影响的研究进展[J].口腔医学,2018,38(7):577-581.
[2] Byun SH, Lee S, Kang SH, et al. Cross-sectional analysis of the association between periodontitis and cardiovascular disease using the Korean genome and epidemiology study data [J]. Int J Environ Res Public Health, 2020, 17(14):5237.
[3] Lee S, Im A, Burm E, et al. Association between periodontitis with blood lipid levels in Korean population [J]. J Periodontol, 2018, 89(1):28-35.
[4] Qin J, Li R, Raes J. A human gut microbial gene catalogue established by metagenomic sequencing [J]. Nature, 2010, 464(7285):59-65.
[5] Sommer F, Bäckhed F. The gut microbiota-masters of host development and physiology [J]. Nat Rev Microbiol, 2013, 11(4):227-238.
[6] Lourenço TGB, Spencer SJ, Alm EJ, et al. Defining the gut microbiota in individuals with periodontal diseases: an exploratory study [J]. J Oral Microbiol, 2018, 10(1):1487741.
[7] Liu B, Zhang Y, Wang R, et al. Western diet feeding influences gut microbiota profiles in apoE knockout mice [J]. Lipids Health Dis, 2018, 17(1):159.
[8] Yu Y, Raka F, Adeli K. The role of the gut microbiota in lipid and lipoprotein metabolism [J]. J Clin Med, 2019, 8(12):2227.
[9] Behera J, Ison J, Tyagi SC, et al. The role of gut microbiota in bone homeostasis [J]. Bone, 2020, 135:115317.
[10] Xu J, Duan X. Association between periodontitis and hyperlipidaemia: A systematic review and meta-analysis [J]. Clin Exp Pharmacol Physiol, 2020, 47(11):1861-1873.
[11] 陈小玲,赵欣,李艳芬,等.大鼠高脂血症与牙周炎相关性实验研究[J].中国实用口腔科杂志,2012,5(2):89-92.
[12] Fu Y, Li X, Xu H, et al. Effects of periodontal therapy on serum lipid profile and proinflammatory cytokines in patients with hyperlipidemia: a randomized controlled trial [J]. Clin Oral Investig, 2016, 20(6):1263-1269.
[13] Cui D, Li H, Lei L, et al. Nonsurgical periodontal treatment reduced aortic inflammation in ApoE ^-/- mice with periodontitis [J]. Springerplus, 2016, 5(1):940.
[14] 吕春旭,孙钦峰.牙周炎与高脂血症的相关性及其机制[J].国际口腔医学杂志,2013,40(5):612-615.
[15] Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota [J]. Sci Rep, 2014, 4(1):4828.
[16] Huang Y, Liao Y, Luo B, et al. Non-surgical periodontal treatment restored the gut microbiota and intestinal barrier in apolipoprotein E^-/- mice with periodontitis [J]. Front Cell Infect Microbiol, 2020, 10:498.
[17] Pedersen AM, Bardow A, Jensen SB, et al. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion [J]. Oral Dis, 2002, 8(3):117-129.
[18] Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body [J]. PLoS Biol, 2016, 14(8):e1002533.
[19] Imhann F, Bonder MJ, Vila AV, et al. Proton pump inhibitors affect the gut microbiome [J]. Gut, 2015, 65(5):740-748.
[20] Sato K, Takahashi N, Kato T, et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system [J]. Sci Rep, 2017, 7(1):6955.
[21] Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation [J]. Science, 2017, 358(6361):359-365.
[22] Kitamoto S, Nagao-Kitamoto H, Jiao Y, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis [J]. Cell, 2020, 182(2):447-462.
[23] Schmidt TS, Hayward MR, Coelho LP, et al. Extensive transmission of microbes along the gastrointestinal tract [J]. Elife, 2019, 8:e42693.
[24] Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage [J]. Proc Natl Acad Sci U S A, 2004, 101(44):15718-15723.
[25] Zhou D, Pan Q, Shen F, et al. Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota [J]. Sci Rep, 2017, 7(1):1529.
[26] Li C, Li X, Han H, et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials [J]. Medicine (Baltimore), 2016, 95(26):e4088.
[27] Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics [J]. Appl Environ Microbiol, 2006, 72(3):1729-1738.
[28] 王萍,王颖,万红,等.肠道菌群在代谢综合征发病机制中的作用[J].中国糖尿病杂志,2020,28(2):147-149.
[29] Fang W, Xue H, Chen X, et al. Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates high-fat diet-induced obesity in mice [J]. J Nutr, 2019, 149(5):747-754.
[30] 曾志青,李金凤,谢笛,等.脂多糖对小鼠巨噬细胞ABCA1表达和胆固醇流出的影响[J].中南医学科学杂志,2014,42(2):139-143.
[31] 王琼,周利,邹燃,等.电针丰隆穴对高脂血症患者血脂水平及对巨噬细胞ABCA1表达的影响[J].安徽中医药大学学报, 2020, 39(5):54-59.
[32] Lee S, Im A, Burm E, et al. Association between periodontitis with blood lipid levels in Korean population [J]. J Periodontol, 2017, 89(1):28-35.
[33] Awartani F, Atassi F. Evaluation of periodontal status in subjects with hyperlipidemia [J]. J Contemp Dent Pract, 2010, 11(2):33-40.
[34] K?rz?oğlu FY, Özmen Ö, Doan B, et al. Effects of rosuvastatin on inducible nitric oxide synthase in rats with hyperlipidaemia and periodontitis [J]. J Periodontal Res, 2018, 53(2):258-266.
[35] Lei L, Li H, Yan F, et al. Hyperlipidemia impaired innate immune response to periodontal pathogen porphyromonas gingivalis in apolipoprotein E knockout mice [J]. PLoS One, 2013, 8(8):e71849.
[36] 杨五洲,曹奇,唐朝克.高脂血症与骨质疏松[J].中国动脉硬化杂志, 2016, 24(3):321-324.
[37] Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes [J]. Science, 2011, 334(6052):105-108.
[38] Qin Y, Roberts JD, Grimm SA, et al. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression [J]. Genome Biol, 2018, 19(1):7.
[39] Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance [J]. Diabetes, 2007, 56(7):1761-1772.
[40] Mulders RJ, de Git KCG, Schéle E, et al. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems [J]. Obes Rev, 2018, 19(4):435-451.
[41] Zhou D, Pan Q, Xin FZ, et al. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier [J]. World J Gastroenterol, 2017, 23(1):60-75.
[42] Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL-10^-/- mice [J]. Nature, 2012, 487(7405):104-108.
[43] Brito F, de Barros FC , Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis [J]. J Clin Periodontol, 2008, 35(6):555-560.
[44] Al-Rasheed A, Scheerens H, Srivastava AK, et al. Accelerated alveolar bone loss in mice lacking interleukin-10: late onset [J]. J Periodontal Res, 2004, 39(3):194-198.
[45] Pietropaoli D, Del Pinto R, Corridoni D, et al. Occurrence of spontaneous periodontal disease in the SAMP1/YitFc murine model of Crohn disease [J]. J Periodontol, 2014, 85(12):1799-1805.
[46] Ikram S, Hassan N, Raffat MA, et al. Systematic review and meta-analysis of double-blind, placebo-controlled, randomized clinical trials using probiotics in chronic periodontitis [J]. J Investig Clin Dent, 2018, 9(3):e12338.
[47] Gatej SM, Marino V, Bright R, et al. Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis [J]. J Clin Periodontol, 2018, 45(2):204-212.
[48] Tyagi AM, Yu M, Darby TM, et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression [J]. Immunity, 2018, 49(6):1116-1131.
[49] Jia X, Jia L, Mo L, et al. Berberine ameliorates periodontal bone loss by regulating gut microbiota [J]. J Dent Res, 2019, 98(1):107-116.
[50] Sulijaya B, Takahashi N, Yamazaki K, et al. Lactobacillus-derived bioactive metabolites for the regulation of periodontal health: evidences to clinical setting [J]. Molecules, 2020, 25(9):2088.
[51] Yan J, Charles JF. Gut microbiome and bone: to build, destroy, or both? [J]. Curr Osteoporos Rep, 2017, 15(4):376-384.
[52] Dar HY, Pal S, Shukla P, et al. Bacillus clausii inhibits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model [J]. Nutrition, 2018, 54:118-128.
[53] Kobayashi R, Kobayashi T, Sakai F, et al. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis -accelerated periodontal disease [J]. Sci Rep, 2017, 7(1):545.
[54] Schwarzer M, Makki K, Storelli G, et al. Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition [J]. Science, 2016, 351(6275):854-857.
[55] Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum [J]. Cell, 2008, 135(5):825-837.